Earnings Call · Q4 FY2022·2023-02-15

Q4 22EPS +100.00%*·Rev n/aQ3 22EPS +70.83%·Rev n/aQ2 22EPS +16.67%·Rev n/aQ1 22EPS +57.58%·Rev n/a⚠ consensus missing

10x Genomics, Inc. TXG

Cassie Corneau — Investor Relations

Serge Saxonov — Chief Executive Officer

Justin McAnear — Chief Financial Officer

+11.2%1d on move date+12.5% vs SPY3d+4.0%5d+3.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TXG calls or request research access.

More TXG calls Browse calls Request research access